Compared to GIP, which has normal secretion but poor response in patients with T2D, GLP-1, which has low secretion but preserved response, is an important target in the development of antidiabetic drugs
A medical consultation determines suitability based on individual health history and goals
As-needed protocol: Use DSIP only during periods of elevated stress or sleep difficulty Maintain for 2-4 weeks as needed Discontinue when sleep normalizes This conservative approach treats DSIP as a targeted intervention rather than ongoing supplementation
Pregnant or breastfeeding women should avoid AOD-9604 due to lack of safety data in these populations
Generic liraglutide tends to cost significantly less than brand-name GLP-1 medications like Ozempic, Wegovy, and Zepbound when paying out-of-pocket
Adhesion failures The most common complaint is fundamental